TP53 and neoplasm: Indeed, CTM specifically inhibits proliferation and tumor growth of multiple cancer cells expressing R175H mutp53 with upregulation of TP53 target genes including p21, PUMA, and MDM2, as well as mutp53’s binding to the TP53-resposible elements of these genes.